
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. (VERA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VERA · as of Jun 8, 2026
Key Statistics
Explore Vera Therapeutics, Inc. Data
vera stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 92.9%
The VERA analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $68.50, representing +115.75% upside from the current price of $31.75.
Competitors & Peers
vera competitorsStock Performance
Full HistoryAbout Vera Therapeutics, Inc.
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United St…
what is vera therapeutics, inc. · vera stock overview · vera therapeutics, inc. company profile · who is vera therapeutics, inc. ceo · vera NASDAQ · vera therapeutics, inc. headquarters · vera therapeutics, inc. business segments
About Stock Overview & Key Data
Vera Therapeutics, Inc. (VERA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 14, 2021. As of the latest trading session, VERA stock price is $31.75, with a market capitalization of $2.3B. The stock has returned +45.38% over the past 12 months and -36.30% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Vera Therapeutics, Inc. stock is Buy, with an average 12-month price target of $68.50. In fiscal year 2025, Vera Therapeutics, Inc. reported revenue of — and net income of -$299.6M. For detailed data — including Vera Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Vera Therapeutics, Inc. (VERA) stock price is $31.75. The stock is traded on NASDAQ under the ticker symbol VERA. The 52-week range is $19.07 – $56.05.